Leon Wang
Stock Analyst at Barclays
(2.94)
# 1,620
Out of 4,749 analysts
11
Total ratings
71.43%
Success rate
26.84%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Leon Wang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Overweight | $40 → $63 | $76.58 | -17.73% | 5 | May 29, 2024 | |
| RAPT RAPT Therapeutics | Downgrades: Equal-Weight | $13 → $4 | $1.14 | +250.88% | 3 | May 10, 2024 | |
| MLTX MoonLake Immunotherapeutics | Maintains: Equal-Weight | $41 → $59 | $45.99 | +28.29% | 3 | Sep 12, 2023 |
Insmed
May 29, 2024
Maintains: Overweight
Price Target: $40 → $63
Current: $76.58
Upside: -17.73%
RAPT Therapeutics
May 10, 2024
Downgrades: Equal-Weight
Price Target: $13 → $4
Current: $1.14
Upside: +250.88%
MoonLake Immunotherapeutics
Sep 12, 2023
Maintains: Equal-Weight
Price Target: $41 → $59
Current: $45.99
Upside: +28.29%